Track the 카이바이오텍 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 카이바이오텍 has logged 13 reports. The latest transaction was filed on 20 September 2024 (Purchase). Among the most active insiders: 케이비인베스트먼트. Every trade is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Kai Biotech es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para el cuidado de la salud.